在高容量医疗系统实施全髋关节置换术临床路径:对住院时间、出院去向及90天并发症的影响
该研究在11家医院实施全髋关节置换术(THA)围手术期临床路径,纳入2013年(路径前)、2014年(过渡期)和2015年(完全实施)共6090例初次THA。完全实施路径与住院时间降低(均值比0.747,95%CI 0.727–0.767)和出院回家增加(OR 2.079,95%CI 1.762–2.456)相关,但与90天并发症无显著关联(OR 1.023,95%CI 0.841–1.245)。作者结论为路径成功降低住院时间并增加出院回家,但未改变90天并发症,该领域需进一步针对性干预。
要点
- 完全实施THA临床路径与住院时间降低相关(均值比0.747,95%CI 0.727–0.767)。
- 完全实施路径与出院回家增加相关(OR 2.079,95%CI 1.762–2.456)。
- 完全实施路径与90天并发症无显著关联(OR 1.023,95%CI 0.841–1.245)。
核心结论
- THA临床路径实施成功降低了住院时间并增加了出院回家。
- 临床路径与90天并发症变化无关联;该领域需进一步针对性干预。
- 尽管进行了护理标准化,高容量医院和外科医生表现更好。
研究设计与样本
- 多学科团队制定了基于证据的THA围手术期临床路径。
- 分析纳入2013年(路径前,历史对照)、2014年(过渡期)和2015年(完全实施路径)所有接受THA的患者。
- 采用多变量回归评估临床路径与90天术后并发症、住院时间和出院去向的关系。
- 成本节约使用先前发表的关节置换术后 episode 和每日住院成本进行估算。
主要发现
- 研究期间共实施6090例初次THA。
- 调整协变量后,完全实施路径与住院时间降低相关(均值比0.747;95%CI 0.727–0.767)。
- 完全实施路径与出院回家增加相关(OR 2.079;95%CI 1.762–2.456)。
- 完全实施路径与90天并发症变化无关联(OR 1.023;95%CI 0.841–1.245)。
- 包括指数入院和出院后成本在内的支付方视角计算的理论成本节约为每例患者2533美元。
关键数值与推荐
- 完全实施路径的住院时间均值比为0.747(95%CI 0.727–0.767)。
- 完全实施路径的出院回家OR为2.079(95%CI 1.762–2.456)。
- 完全实施路径的90天并发症OR为1.023(95%CI 0.841–1.245)。
- 支付方视角计算的理论成本节约为每例患者2533美元。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Standardized care pathways are evidence-based algorithms for optimizing an episode of care. Despite the theoretical promise of care pathways, there is an inconsistent literature demonstrating improvements in patient care. The authors hypothesized that implementing a care pathway, across 11 hospitals, would decrease hospital length of stay (LOS), decrease postoperative complications at 90 days, and increase discharges to home. METHODS: A multidisciplinary team developed an evidence-based care pathway for total hip arthroplasty (THA) perioperative care. All patients receiving THA in 2013 (pre-protocol, historical control), 2014 (transition), and 2015 (full protocol implementation) were included in the analysis. Multivariable regression assessed the relationship of the care pathway to 90-day postoperative complications, LOS, and discharge disposition. Cost savings were estimated using previously published postarthroplasty episode and per diem hospital costs. RESULTS: A total of 6090 primary THAs were conducted during the study period. After adjusting for the covariates, the full protocol implementation was associated with a decrease in LOS (mean ratio, 0.747; 95% confidence interval [CI; 0.727, 0.767]) and an increase in discharges to home (odds ratio, 2.079; 95% CI [1.762, 2.456]). The full protocol implementation was not associated with a change in 90-day complications (odds ratio, 1.023; 95% CI [0.841, 1.245]). Payer-perspective-calculated theoretical cost savings, including both index admission and postdischarge costs, were $2533 per patient. CONCLUSION: The THA care pathway implementation was successful in reducing LOS and increasing discharges to home. The care pathway was not associated with a change in 90-day complications; further targeted interventions in this area are needed. Despite care standardization efforts, high-volume hospitals and surgeons had higher performance. Extrapolation of theoretical cost savings indicates that widespread THA care pathway adoption could lead to national healthcare savings of $1.2 billion annually.
引用
- Featherall J, Brigati DP, Faour M, et al. Implementation of a Total Hip Arthroplasty Care Pathway at a High-Volume Health System: Effect on Length of Stay, Discharge Disposition, and 90-Day Complications. J Arthroplasty. 2018. PMID: 29478678. doi:10.1016/j.arth.2018.01.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。